Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Capitol Capsule: No sign FDA chief sought stronger powers before meningitis crisis

This article was originally published in Scrip

Executive Summary

Since reports first emerged about infections caused by medicines contaminated with fungus and bacteria compounded by a Massachusetts pharmacy – with more than 400 Americans sickened by the tainted drugs so far – the US FDA has emphasized it lacks authority to properly regulate those entities and insisted regulators are working to prevent a similar catastrophe in the future.

Topics

Related Companies

UsernamePublicRestriction

Register

SC019339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel